Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly...

The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...

The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people...

Cancer vaccine shows promise A new cancer vaccine, mRNA-4359, developed by Moderna, could revolutionise cancer treatment. This vaccine is designed...

Around 58 million people suffer from chronic inflammation caused by the hepatitis C virus, and 300,000 people die from the disease every year. So...

Immune checkpoint blockade (ICB) is one of the primary methods of tumour immunotherapy. It involves reactivating the immune system, which cancer has...

In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the...

The World Health Organisation (WHO) has prequalified an Mpox vaccine for the first time, marking a significant milestone in the global fight against...

The World Health Organisation (WHO) has prequalified an Mpox vaccine for the first time, marking a significant milestone in the global fight against...

Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...